Table: Brightpath Biotherapeutics - 9-MTH parent results

BrightPath Biotherapeutics Co

10/02/2023 06:00

Feb 10 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2022        Dec 31, 2021      Mar 31, 2023  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             5 mln               0 mln             5 mln     
                                     (-82.1 pct)       (-67.6 pct)  
  Operating       loss 1.22           loss 1.07         loss 1.64   
  Recurring       loss 1.22           loss 1.08         loss 1.64   
  Net             loss 1.23           loss 1.08         loss 1.64   
  EPS          loss 20.91 yen      loss 20.96 yen    loss 29.63 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T